CYBN Insider Trading Activity
Transactions disclosed by company insiders to the SEC on Form 4, most recent first.
Data compiled from public SEC filings. This is informational reporting, not investment advice.
Cybin Inc. (CYBN) Chief Growth Officer Paul Glavine purchased 100,000 shares of the company on the open market on September 8, 2026, paying $12.47 per share for a total outlay of $1,247,190.00. Following the purchase, Glavine holds 4,271,252 shares directly, according to a Form 4 filed with the SEC. The transaction was not an isolated … Read more
Eric H. L. So, Executive Chair of Cybin Inc. (CYBN), disclosed another open-market purchase of company stock in a Form 4 filing, adding to a fast-growing cluster of insider buying at the biotech firm. According to the filing, So bought 100,000 shares on September 8, 2026 at $12.39 per share, a purchase worth $1,238,670. Following … Read more
Eric H. L. So, Executive Chair of Cybin Inc. (CYBN), purchased 100,000 shares of the company on the open market on September 4, 2026, paying $12.09 per share for a total outlay of $1,208,900.00. Following the purchase, So holds 4,365,014 shares directly, according to a Form 4 filed with the SEC. The purchase did not … Read more
A newly filed Form 4 shows Paul Glavine, Chief Growth Officer of Cybin Inc. (CYBN), purchased 100,000 shares of company stock on the open market on September 3, 2026, at a price of $11.78 per share. The transaction, funded with Glavine’s own money rather than through options or other compensation mechanisms, totaled $1,178,280.00. Following the … Read more